ATLATL and Samsung Bioepis Launch 'Samsung Bioepis Innovation Prize C-Lab Outside' to Accelerate Early-Stage Biotech Innovation Across Asia-Pacific

Applications Open June 25 for Early-Stage Biotech Companies Developing Next-Generation Therapeutics and Platform Technologies

SHANGHAI, June 25, 2026 /PRNewswire/ -- ATLATL Innovation Center ("ATLATL"), a global innovation platform for life science research and development, and Samsung Bioepis Co., Ltd., today announced the launch of the Samsung Bioepis Innovation Prize C-Lab Outside (Innovation Prize), an open innovation initiative designed to identify and support promising early-stage biotech companies across the Asia-Pacific region.

Applications for the Innovation Prize will open on June 25, 2026.

The program seeks innovative startups and emerging biotech companies working in the following therapeutic areas:

• Oncology
• Immunology & Inflammation (I&I)
• Metabolic Disease

Areas of particular interest include:

• Novel/New Mechanisms of Action (MoA)-based Antibody-Drug Conjugate (ADC)/ X-Drug Conjugates (XDC) (i.e., Payload, Linker, Conjugation)
• Antibody Engineering Technology
• New Modality (Biologics)
• Peptide (Design Engineering, Long-acting Peptide)
• Novel Target Discovery Platform

Selected companies will gain access to ATLATL's world-class laboratory infrastructure, entrepreneurial resources, and industry mentorship. In addition, awardees will have the opportunity to engage with Samsung Bioepis through its open innovation platform, enabling scientific collaboration, technology assessment, and potential future partnership opportunities. Together, these resources are designed to accelerate innovation and support the translation of promising technologies toward commercialization.

"Innovation thrives when visionary science is matched with the right support and opportunities," said Min Jeong Seo, Vice President and Leader of Open Innovation Team at Samsung Bioepis. "Through the Innovation Prize, we are seeking to empower promising biotech entrepreneurs and researchers who are advancing novel approaches to address unmet medical needs. By fostering collaboration across the Asia-Pacific region, we hope to help accelerate scientific innovation and contribute to a strong ecosystem for the development of future medicines."

"Great science alone does not create successful biotech companies," said Dr. PC Zhu, Founder and CEO of ATLATL. "Innovators need access to world-class infrastructure, R&D ecosystem, experienced mentors, strategic partners, and capital to move forward. By bringing together Samsung Bioepis' global development expertise and ATLATL's innovation ecosystem, we hope to provide early-stage biotech entrepreneurs with the resources and support needed to accelerate innovation and deliver meaningful impact to patients."

The Samsung Bioepis Innovation Prize C-Lab Outside reflects both organizations' commitment to advancing open innovation and supporting the next generation of biotechnology entrepreneurs. By bringing together scientific talent, development expertise, and critical infrastructure, the program aims to accelerate the translation of breakthrough research into transformative therapies for patients worldwide. The Innovation Prize is also part of Samsung Bioepis C-Lab Outside, Samsung Bioepis' open innovation program designed to discover, nurture, and collaborate with competent and prospective biotech ventures and startups in and outside of Korea.

About ATLATL

As a global innovation platform for life science research and development, ATLATL has established research centers in Beijing, Shanghai, Shenzhen, Singapore, Hong Kong, and other strategic locations.

ATLATL provides clients with comprehensive research and development services covering various stages, including in vitro drug screening, in vivo disease model establishment, and efficacy evaluation. ATLATL also supports key applications such as large molecule, small molecule, nucleic acid drugs, gene and cell therapy, drug delivery, as well as cutting-edge fields like multi-omics, gene editing, organoids, and organ-on-a-chip. Additionally, ATLATL provides an outstanding experimental environment and professional operational management for scientific researchers.

Through in-depth cooperation with leading global enterprises and research institutions, ATLATL continuously integrates research and development resources and promotes the sharing of new technologies. With advanced systematic research and development models, ATLATL accelerates the engineering process of life sciences, enabling scientific research results to be rapidly and efficiently translated into clinical practice, and contributing to life science innovation and public health on a global level.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

ATLATL and Samsung Bioepis Launch 'Samsung Bioepis Innovation Prize C-Lab Outside' to Accelerate Early-Stage Biotech Innovation Across Asia-Pacific

MUNICH, June 25, 2026 /PRNewswire/ -- From June 23 to 25, HiTHIUM showcased its energy storage portfolio at The Smarter E Europe 2026, including the world's first native 8-hour long-duration energy storage (LDES) solution, the ∞Power 6.9MWh BESS, the newly launched ∞Power 1022kWh liquid-cooled C&I energy storage cabinet, and the ARKVOLT residential energy storage solutions series. Together, the products demonstrated HiTHIUM's integrated energy storage solution capabilities across source-grid-load scenarios from 1 to 8 hours.

Europe is accelerating its energy transition. As wind and solar installations grow, power systems require more flexible resources. Frequent negative electricity prices, rising grid-balancing pressure and increasing renewable energy consumption needs are driving the energy storage market from short-duration applications toward LDES, making it key infrastructure for power systems with high renewable energy penetration.

To address new requirements for economic performance, safety, reliability and scalable delivery, HiTHIUM has built a technical system from dedicated cells to system integration. At the exhibition, HiTHIUM highlighted the ∞Power 6.9MWh 8h BESS. Based on the world's first 1300Ah cell dedicated to 8h LDES, the system achieves more than 6.9MWh capacity and stable 8-hour output in a standard 20-foot container. With a design life of up to 25 years and support for flexible deployment, it helps reduce station footprint and construction costs. Its low-GWP coolant, anti-leakage design and recyclable structural components support environmental performance, while intrinsic cell safety, battery compartment protection and intelligent BMS management form a multi-layer safety architecture.

HiTHIUM also launched the ∞Power 1022kWh liquid-cooled C&I energy storage cabinet for global commercial and industrial markets. Equipped with HiTHIUM's self-developed ∞Cell 1175Ah large-capacity cell and a 1P272S system architecture, the product has a nominal capacity of 1022.72kWh per cabinet, supports a 0.25P charge and discharge rate, and keeps system DC voltage within 1000V. Through large-capacity cells, high integration, liquid cooling and intelligent energy management, the cabinet improves system integration efficiency, land-use efficiency, installation convenience and lifecycle economics. Compared with conventional multi-cabinet parallel solutions, it can reduce footprint by approximately 32% and achieve capacity density of around 300kWh/m². Designed for international deployment, it uses an environmentally friendly refrigerant, supports a wide operating temperature range, and adopts IP55 protection and C5M anti-corrosion design.

The exhibition also marked the European debut of HiTHIUM's residential energy storage business and the global launch of its new premium residential brand, ARKVOLT.  The ARKVOLT portfolio includes three product lines: R30, F8S and L16/L16S. Powered by HiTHIUM's self-developed ∞Cell 587Ah large-capacity cell, the R30 series further optimizes energy density, system efficiency and lifecycle cost for large homes and light C&I applications. The F8S series targets premium whole-home backup, while the L16/L16S series focuses on high returns and flexible expansion, covering home backup to light C&I scenarios. ARKVOLT's global debut marks a strategic extension of HiTHIUM's end-user energy service capabilities, supporting its shift from product globalization to brand globalization and laying a foundation for its global residential energy storage ecosystem.

During the exhibition, HiTHIUM signed strategic agreements with European partners including Turbo Energy, S.A., to deepen local deployment in long-duration storage integrated with AI energy management and C&I applications. Concurrently, HiTHIUM's ∞Power 6.25MWh 4h LDES BESS achieved outstanding performance in large-scale fire tests, earning certification from UL Solutions while also passing TÜV Rheinland's assessment, thereby securing both UL 9540 and IEC 62933-5-2 certifications. This reinforces HiTHIUM's leadership in large–cell and system safety, and providing a solid foundation for global project scaling.

As renewable energy penetration continues to increase, LDES is moving toward large-scale application. HiTHIUM will continue to focus on LDES, technology innovation and global deployment, expanding its integrated portfolio across energy storage cells, systems and full-scenario applications to support global customers and the green energy transition.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

HiTHIUM Showcases Full-Scenario Product Portfolio at The Smarter E Europe 2026, Accelerating Europe's Energy Transition with Long-Duration Solutions